How Europe’s SPC regime works in practice
As the European Commission aspires to introduce a Unitary SPC, Tony Rollins examines the evidence on how effective the existing regime for patent extension in Europe has been
The pharmaceutical industry is often cited as an industry where the IP system is crucial for innovation. Research and development costs are high, the development periods are lengthy and there is a high risk of failure. In their article "Returns...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.